Libri sul tema "Small Cell Lung Cancer"

S, Seeber, ed. Small cell lung cancer. Berlin: Springer-Verlag, 1985.

Seeber, Siegfried, ed. Small Cell Lung Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-82372-5.

T, Carr David, and International Cancer Research Data Bank., eds. Non-small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Jerome, Seidenfeld, Blue Cross and Blue Shield Association. Technology Evaluation Center., and United States. Agency for Healthcare Research and Quality., eds. Management of small cell lung cancer. Rockville, MD: Agency for Healthcare Research and Quality, Public Health Service, U.S. Dept. of Health and Human Services, 2006.

Postmus, Pieter Edsge. New approaches in small cell lung cancer. [s.l.]: [s.n.], 1985.

Carr, David T. Selected abstracts on small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1986.

Ramaswamy, Govindan, ed. Locally advanced non-small-cell lung cancer. Manhasset, NY: CMP United Business Media, 2004.

1935-, Skarin Arthur T., and Alexander Eben, eds. Multimodality treatment of lung cancer. New York: M. Dekker, 2000.

IASLC Workshop on Small Cell Lung Cancer (3rd 1989 Helsingør, Denmark). Management of small cell lung cancer: Third IASLC Workshop on Small Cell Lung Cancer, Elsinore, Denmark, 18-22 June, 1989. Edited by Hansen Heine Høi, Kristjansen Paul E. G, and International Association for the Study of Lung Cancer. Amsterdam: Elsevier, 1989.

Benjamin, Movsas, Langer Corey J, and Goldberg Melvyn, eds. Controversies in lung cancer: A multidisciplinary approach. New York: M. Dekker, 2001.

M, Marangolo, and Fiorentini G, eds. Small cell lung cancer: Proceedings of the International Conference on Small Cell Lung Cancer, 27-28 March 1987, Ravenna, Italy. Oxford: Pergamon Press, 1988.

International Workshop on Small Cell Lung Cancer Antigens (2nd 1990 Royal Society of Medicine). Small cell lung cancer antigens: Proceedings of the Second International Workshop on Small Cell Lung Cancer Antigens held at the Royal Society of Medicine, 25-27 April 1990. [Basingstoke, Hampshire: published for Cancer Research Campaign by Macmillan, 1991.

Ettinger, David S. The role of chemotherapy in non-small cell lung cancer. Syracuse, NY: Bristol Laboratories Oncology Products, Bristol-Myers Oncology Division, 1986.

Bunn, Paul A. VePesid (etoposide injection), its role in small cell lung cancer. Syracuse, N.Y: Bristol-Myers, Oncology Division, 1985.

G, Maldonado Jonathon, and Cervantes Mikayla K, eds. Small cell carcinomas: Causes, diagnosis and treatment. Hauppauge, N.Y: Nova Science, 2009.

Maldonado, Jonathon G. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

McCracken, Joseph D. Concurrent chemotherapy and radiation therapy for limited small cell lung cancer. Syracuse, N.Y: Bristol-Myers, Oncology Division, 1986.

Banerjee, Srabani. Treatment of inoperable advanced non-small-cell lung cancer: Regimens with or without taxane. Ottawa: Canadian Coordinating Office for Health Technology Assessment, 2002.

Young, Sean Steven. Lactic acid transport in small cell lung cancer cell lines NCI-H69 and NCI-H69AR. Sudbury, Ont: Laurentian University Press, 1995.

Kashyap, Amita, D. Bujamma, and Naresh Babu M. Bioinformatics of Non Small Cell Lung Cancer and the Ras Proto-Oncogene. Singapore: Springer Singapore, 2015. http://dx.doi.org/10.1007/978-981-4585-08-8.

author, Bujamma D., and M., Naresh Babu (Muppalaneni), author, eds. Bioinformatics of non small cell lung cancer and the ras proto-oncogene. Heidelberg: Springer-Verlag, 2015.

Jørgensen, Lone G. M. Neuron specific enolase in small cell lung cancer: Clinical and biochemical evaluation. København: Lægeforeningens Forlag, 1998.

Maldonado, Jonathon G., and Mikayla K. Cervantes. Small cell carcinomas: Causes, diagnosis and treatment. New York: Nova Biomedical Books, 2009.

Dubois, Natalie C. Inhibition of small cell lung cancer cell line (H-69) with the calcium channel blocker, Verapamil. Sudbury, Ont: Laurentian University, 1995.

Ross, Jama. Energy metabolism in small cell lung cancer lines H-69 and H-69AR. Sudbury, Ont: Laurentian University, 1995.

Birnkrant, David Jonathan. Small cell cancer of the lung: An initial evaluation of the Yale treatment protocol. [New Haven: s.n.], 1985.

Ozog, Mark. The energy metabolism of a small cell lung cancer cell line, H69, and its drug resistant derivative, H69AR. Sudbury, Ont: Laurentian University, Department of Biology, 1995.

H, Einhorn Lawrence, and Gralla Richard J, eds. Treatment and prevention of small cell lung cancer and non-small cell lung cancer: Proceedings of an international symposium sponsored by Bristol-Myers Oncology Division, held in London, England, 28 August, 1988. London: Royal Society of Medicine Services, 1989.

1940-, Hayat M. A., ed. Lung and breast carcinomas. Amsterdam: Elsevier, Academic Press, 2008.

Mazzuchin, Chris. Inhibition of lactic acid transport in small cell lung cancer H69 by alpha-cyano-3-hydroxycinnamate. Sudbury, Ont: Laurentian University, 1995.

Smith, Ronald Dee. Veterinary clinical epidemiology: A problem-oriented approach. Boston: Butterworth-Heinemann, 1991.

Hann, Brad. The Inhibitory effects of alpha-cyano-4-hydroxycinnamic acid on the lactate transporter of H69 small cell lung cancer cells. Sudbury, Ont: Laurentian University, 1995.

Tammemagi, Martin Carl. Tobacco smoking, p53 tumour suppressor gene alterations, and clinicopathologic features and prognosis in non-small cell lung cancer. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1998.

Wake, Beverley. Hyperfractionated-accelerated radiotherapy regimens for the treatment of non-small cell lung cancer: A systematic review of clinical and cost-effectiveness. Birmingham: University of Birmingham, Department of Public Health and Epidemiology, 2002.

National Institute for Clinical Excellence., ed. Guidance on the use of docetaxel, paclitaxel,gemcitabine and vinorelbine for the treatment of non-small cell lung cancer. London: NICE, 2001.

Rogers, M. J. A phenomenological investigation of the patient's experience in the first month following palliative radiotherapy for non-small cell lung cancer. Oxford: Oxford Brookes University, 2000.

Seeber, Siegfried. Small Cell Lung Cancer. Springer, 2012.

Seeber, Siegfried, and Alexander Petroianu. Small Cell Lung Cancer. Brand: Springer, 2012.

Small Cell Lung Cancer. Springer, 2011.

Azzoli, Christopher G. Non-Small Cell Lung Cancer. Jones & Bartlett Learning, LLC, 2009.

Non-small cell lung cancer. Bethesda, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, International Cancer Research Data Bank, 1988.

Non-Small Cell Lung Cancer Treatment. UNI-MED Verlag AG, 2007.

Non-Small Cell Lung Cancer Treatment. UNI-MED Verlag AG, 2007.

Hansen, Heine H. Management of Small Cell Lung Cancer. Elsevier Science Ltd, 1990.

Giaccone, Giuseppe. Systemic Treatment of Non-Small Cell Lung Cancer. Oxford University Press, 2012.

Fast Facts: Non-Small-Cell Lung Cancer. Karger AG, S., 2016.

Awad, M. M., B. Besse, and M. O'Brien. Fast Facts: Non-Small-Cell Lung Cancer. Karger AG, S., 2022.

Non-Small Cell Lung Cancer: New Research. Nova Science Pub Inc, 2013.

Fast Facts: Non-Small-Cell Lung Cancer. Karger AG, S., 2022.

Giaccone, Giuseppe, ed. Systemic Treatment of Non-Small Cell Lung Cancer. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199580484.001.0001.